Navigation Links
Omthera Pharmaceuticals Announces Positive Top-Line Results from Phase 3 EVOLVE Study
Date:4/26/2012

he complete data set at an upcoming scientific meeting."

Dr. Michael Davidson, Co-Founder and Chief Medical Officer of Omthera, stated, "In addition to the triglyceride lowering benefit, we were pleased to observe from these top-line results a meaningful decrease of 8% in non-HDL-cholesterol in both the 2 and 4 gram dose groups.  We believe these data will be important for Epanova in light of the growing reliance of the medical community (Journal of the American Medical Association, March 28, 2012 – Vol 307, No 12) on non-HDL-cholesterol as the more accurate arbiter of the risk for cardiovascular disease, especially in patients with hypertriglyceridemia. We have recently completed enrollment and randomization in ESPRIT, our 647 patient statin combination study.   The primary objective of ESPRIT is to evaluate the efficacy of adding Epanova (2 gram or 4 gram daily) to statin monotherapy for lowering non-HDL-cholesterol.  We look forward to the results from this study, expected in July 2012, to further validate the progression of Epanova as a best-in-class therapy for the treatment of patients with mixed dyslipidemia."

About Epanova™

Epanova is a patent protected, novel, ultra-pure mixture of the free fatty acid forms of eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA). Omthera has developed a substantial body of data on Epanova, which points to an improved and more predictable bioavailability as compared to the ethyl ester form found in prescription Omega-3 products currently available.  Triglyceride lowering with Epanova was previously observed in two large, placebo-controlled, randomized, double-blind, Phase III studies involving 748 Crohn's disease patients with normal triglyceride levels for ≥52 weeks, approximately 400 of which were treated with Epanova for remission of disease. In all studies performed to date, Epanova has demonstrated a very good safety and tolerability pr
'/>"/>

SOURCE Omthera Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Omthera Pharmaceuticals, Inc. to Present at Leerink Swann 2012 Global Healthcare Conference and Citi 2012 Global Healthcare Conference
2. Omthera Pharmaceuticals Announces Positive Long Term Bioavailability Data Comparing Epanova™ to Lovaza®
3. Omthera Pharmaceuticals, Inc. to Present at the 30th Annual J.P. Morgan Healthcare Conference
4. Omthera Pharmaceuticals, Inc. to Present at the 23rd Annual Piper Jaffray Health Care Conference
5. Timothy J. Maines Joins Omthera Pharmaceuticals as Vice President of Quality
6. Omthera Pharmaceuticals, Inc. to Present at the Rodman and Renshaw 13th Annual Healthcare Conference
7. Omthera Pharmaceuticals, Inc. Initiates Phase III ESPRIT Trial of Add-on Epanova™ to Statin Therapy in Patients with Hypertriglyceridemia
8. Christian S. Schade to Join Omthera Pharmaceuticals as Executive Vice President and Chief Financial Officer
9. Drs. Ben Machielse Joins Omthera Pharmaceuticals, Inc. as Chief Operating Officer
10. Omthera Pharmaceuticals, Inc. to Present at the 2011 Wells Fargo Securities Healthcare Conference
11. Omthera Pharmaceuticals, Inc. to Present at the BIO Windhover/Pharmaceutical Strategic Outlook 2011 Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2015)... , July 29, 2015  Mylan N.V. (NASDAQ: ... clearance from the European Commission under the European Union ... Company plc (NYSE: PRGO ; TASE).  ... commented, "Today marks yet another important milestone in the ... as further affirmation of the sound industrial logic of ...
(Date:7/29/2015)... Legal-Bay LLC, The Lawsuit Settlement Funding Company, announced ... the Southern District of West Virginia ... initially set to start in November. The first trial that ... were added and now it involves 39 women, and the ... according to an article in Reuters. The alterations were made ...
(Date:7/28/2015)... Lifesciences Corporation (NYSE: EW ), the global leader ... today reported net income for the quarter ended June 30, ... Adjusted net income on a non-GAAP basis was $124.4 ... per diluted share in the prior year period. In ... per diluted share, which included a $750 million payment ...
Breaking Medicine Technology:Mylan Announces Receipt of Unconditional Clearance from European Commission on Acquisition of Perrigo 2Mylan Announces Receipt of Unconditional Clearance from European Commission on Acquisition of Perrigo 3Mylan Announces Receipt of Unconditional Clearance from European Commission on Acquisition of Perrigo 4Mylan Announces Receipt of Unconditional Clearance from European Commission on Acquisition of Perrigo 5Mylan Announces Receipt of Unconditional Clearance from European Commission on Acquisition of Perrigo 6Mylan Announces Receipt of Unconditional Clearance from European Commission on Acquisition of Perrigo 7Mylan Announces Receipt of Unconditional Clearance from European Commission on Acquisition of Perrigo 8Mylan Announces Receipt of Unconditional Clearance from European Commission on Acquisition of Perrigo 9Judge Pushes Back Single Trial for 26 Ethicon Mesh Cases, says Legal-Bay Lawsuit Settlement Funding 2Judge Pushes Back Single Trial for 26 Ethicon Mesh Cases, says Legal-Bay Lawsuit Settlement Funding 3Edwards Lifesciences Reports Second Quarter Results 2Edwards Lifesciences Reports Second Quarter Results 3Edwards Lifesciences Reports Second Quarter Results 4Edwards Lifesciences Reports Second Quarter Results 5Edwards Lifesciences Reports Second Quarter Results 6Edwards Lifesciences Reports Second Quarter Results 7Edwards Lifesciences Reports Second Quarter Results 8Edwards Lifesciences Reports Second Quarter Results 9Edwards Lifesciences Reports Second Quarter Results 10Edwards Lifesciences Reports Second Quarter Results 11Edwards Lifesciences Reports Second Quarter Results 12Edwards Lifesciences Reports Second Quarter Results 13Edwards Lifesciences Reports Second Quarter Results 14Edwards Lifesciences Reports Second Quarter Results 15Edwards Lifesciences Reports Second Quarter Results 16Edwards Lifesciences Reports Second Quarter Results 17Edwards Lifesciences Reports Second Quarter Results 18Edwards Lifesciences Reports Second Quarter Results 19Edwards Lifesciences Reports Second Quarter Results 20Edwards Lifesciences Reports Second Quarter Results 21Edwards Lifesciences Reports Second Quarter Results 22Edwards Lifesciences Reports Second Quarter Results 23
... LONDON , June 16 Market Publishers Ltd announces that ... available in its catalogue. , , ... The UK Medical Devices Industry: Increasing Incidence of Lifestyle Disorders ... the medical devices industry in the UK. Key markets covered include Diabetes ...
... Henry Schein , Inc., (Nasdaq: HSIC ), the largest provider of health ... , the Company,s Executive Vice President and Chief Financial Officer, will present at ... . The conference is being held at the Hyatt Regency Century Plaza in ... , Henry ...
Cached Medicine Technology:Healthcare Equipment & Services Research June Updates by MarketPublishers.com 2Healthcare Equipment & Services Research June Updates by MarketPublishers.com 3Healthcare Equipment & Services Research June Updates by MarketPublishers.com 4Henry Schein to Present at the Goldman Sachs 31st Annual Global Healthcare Conference 2
(Date:7/29/2015)... ... ... Several years ago, in order to be in the strongest position possible ... stance and began planning the Children’s Village consisting of six homes. , Two are ... third home. , “We are very pleased to have received the $500,000 grant from ...
(Date:7/29/2015)... ... 2015 , ... Toronto native Douglas James Cottrell, Ph.D., has ... been making predictions about the economy, politics, social issues, as well as the ... warns that extreme weather conditions and increased earthquake / volcanic activity will increase ...
(Date:7/29/2015)... ... 29, 2015 , ... National non-profit World T.E.A.M. Sports announced ... employee benefits and asset management, has joined as presenting sponsor for the inaugural ... Charlotte, North Carolina on October 2-4, 2015. , Hosted at the U.S. ...
(Date:7/29/2015)... ... July 29, 2015 , ... One of the world’s ... on the potentially lifesaving impact of removing aluminum from Alzheimer’s disease patients, announced ... proposal is based on a successful pilot study published in The Journal of ...
(Date:7/29/2015)... (PRWEB) , ... July 29, 2015 , ... One may ... in an assisted nursing facility, but that’s exactly what was happening on the campus ... the facility are 3- and 4-year-olds from Kids Only , a five-star childcare ...
Breaking Medicine News(10 mins):Health News:Little City Receives $500,000 Matching Grant from The Coleman Foundation 2Health News:Little City Receives $500,000 Matching Grant from The Coleman Foundation 3Health News:Author Warns Public to Prepare for Imminent Environmental Disaster 2Health News:MetLife Joins World T.E.A.M. Sports’ Adventure Team Challenge North Carolina as Presenting Sponsor 2Health News:MetLife Joins World T.E.A.M. Sports’ Adventure Team Challenge North Carolina as Presenting Sponsor 3Health News:Children's Medical Safety Research Institute Announces Innovative Study on Alzheimer’s Treatment Is Subject of Crowd Funding Campaign 2Health News:Children's Medical Safety Research Institute Announces Innovative Study on Alzheimer’s Treatment Is Subject of Crowd Funding Campaign 3Health News:North Carolina Retirement Community Re-Launches Intergenerational Programming with Onsite Daycare Center 2Health News:North Carolina Retirement Community Re-Launches Intergenerational Programming with Onsite Daycare Center 3Health News:North Carolina Retirement Community Re-Launches Intergenerational Programming with Onsite Daycare Center 4
... July 2 FGX International,(Nasdaq: FGXI ), ... sunglasses and costume jewelry, today announced that Alec ... DiPaola, Chief,Financial Officer will be presenting at the ... 8, 2008 at The Four Seasons Hotel in,Boston., ...
... The Walter and Eliza Hall Institute (WEHI) has ... between Australian biotechnology company, Bionomics, (ASX:BNO) and Germany-based ... Development and Licensing Agreement, Merck Serono will seek ... and other autoimmune conditions. These prospective treatments will ...
... health benefits , , WEDNESDAY, July 2 (HealthDay News) -- ... understanding how relaxation techniques such as meditation, prayer and ... that affect how the body responds to stress. , ... in newer recruits, the scientists said. , "It,s not ...
... July 2 MEDai, Inc., headquartered in,Orlando, FL, ... healthcare,that utilize award-winning predictive analytics to offer a ... needs of health plans,employers, physicians, underwriters and actuaries. ... the identification of,potential misuse of prescription drugs, a ...
... at Grumpy,s Cafe; Works on Sale ... Festival of the Arts, CLEVELAND, July 2 An ... Program is now on display at Grumpy,s,Cafe, 2621 West 14th ... includes several paintings from residents of Joseph,s,Home, a ministry of ...
... Medical, Inc.,(Nasdaq: ATSI ), manufacturer and marketer ... will participate at the Collins,Stewart LLC Fourth Annual ... York City. Michael Dale, President and CEO of ... on Tuesday, July 8, 2008., (Logo: ...
Cached Medicine News:Health News:MS drug development agreement based on WEHI's medicinal chemistry 2Health News:Meditation, Yoga Might Switch Off Stress Genes 2Health News:Meditation, Yoga Might Switch Off Stress Genes 3Health News:MEDai Technology Identifies Prescription Drug Misuse 2Health News:Artwork by Homeless Men on Display in Tremont Cafe 2Health News:Artwork by Homeless Men on Display in Tremont Cafe 3Health News:ATS Medical to Participate at the Fourth Annual Collins Stewart Growth Conference 2
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: